CTP Newsroom
Stay up to date on the latest news and events from FDA's Center for Tobacco Products through the CTP Newsroom.
From press releases to public meetings to email newsletters, stay up to date on the latest news and events from the FDA Center for Tobacco Products.
Latest News
FDA Warns Manufacturer for Marketing Illegal Flavored Nicotine Gummies
FDA issues warning letter to Krave Nic for marketing illegal flavored nicotine gummies without marketing authorization.
August 18, 2022
FDA’s Progress on NTN Review and Enforcement
Brian King, Center for Tobacco Products Director, provides an update on the agency’s review and enforcement of non-tobacco nicotine products.
August 3, 2022
FDA Continues to Implement Law to Regulate NTN Products
FDA warns retailers and manufacturers against illegal sales of non-tobacco nicotine products and remains committed to ongoing enforcement against illegal products.
July 13, 2022
2022
August
- FDA Warns Manufacturer for Marketing Illegal Flavored Nicotine Gummies
- CTPConnect Newsletter: FDA’s Recent Regulatory Actions on Tobacco Products
- Perspective: Update on FDA Review and Enforcement of Non-Tobacco Nicotine Products
July
June
- CTP Statement: June 24, 2022
- FDA Denies Authorization to Market JUUL Products
- FDA Announces Plans for Proposed Rule to Reduce Addictiveness of Cigarettes and Other Combusted Tobacco Products
- Spotlight on Science: FDA Proposes Rules Prohibiting Menthol Cigarettes and Flavored Cigars
- FDA Issues Marketing Decisions on NJOY Daily E-Cigarette Products
- FDA Launches Campaign Aimed at Preventing E-Cigarette Use Among American Indian/Alaska Native Youth
- CTPConnect Newsletter: Catch Up on Recent FDA Tobacco News
- Event - Listening Sessions: FDA’s Recently Proposed Tobacco Product Standards
May
- FDA Issues Marketing Decisions on Vuse Vibe and Vuse Ciro E-Cigarette Products
- Reminder: Electronic Submission of Premarket Applications for Non-Tobacco Nicotine Products due May 14
April
- FDA Proposes Rules Prohibiting Menthol Cigarettes and Flavored Cigars to Prevent Youth Initiation, Significantly Reduce Tobacco-Related Disease and Death
- FDA Issues Marketing Decisions on NJOY Ace E-Cigarette Products
- CTPConnect Newsletter: SE & PMTA Submission Forms, Non-Tobacco Nicotine, & More
- Mitch Zeller Reflects on Experiences as Director of FDA Center for Tobacco Products
- Requirements for Products Made with Non-Tobacco Nicotine Take Effect April 14
- FDA Issues Marketing Denial Orders to Fontem US for myblu Products
March
- New Law Clarifies FDA Authority to Regulate Synthetic Nicotine
- FDA Issues Decisions on Additional E-Cigarette Products
- Spotlight on Science: New Studies and Report Available
- FDA Authorizes Reduced Exposure Claim for IQOS 3 System Holder and Charger
- Newly Released: 2021 NYTS Findings on Youth Use of All Tobacco Products
- CTP Statement on National Academies Report on Premium Cigars Health Effects
February
January
- FDA is Now Accepting Applications for the Position of Director, Center for Tobacco Products (CTP)
- FDA on Track to Take Actions to Address Tobacco-Related Health Disparities
- CTPConnect Newsletter: Quit Smoking in the New Year
December
- FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them
- Final Guidance: Tobacco Product User Fees: Responses to FAQs
- Adjustment of Civil Monetary Penalties for Inflation and the Annual Civil Monetary Penalties Inflation Adjustment for 2021
October
- CTPConnect Newsletter: FDA Permits Marketing of First E-Cigarette Products
- Spotlight on Science Newsletter: NYTS 2021 Released
- FDA Permits Marketing of New Oral Tobacco Products through Premarket Tobacco Product Application Pathway
- FDA Permits Marketing of E-Cigarette Products, Marking First Authorization of Its Kind by the Agency
- FDA In Brief: FDA Warns Firms for Continuing to Market E-cigarette Products After Agency Denied Authorizations
- FDA Finalizes Two Foundational Rules for Companies Seeking to Market New Tobacco Products
September
- Youth E-cigarette Use Remains a Serious Public Health Concern Amid COVID-19 Pandemic
- CTPConnect Newsletter: CTP Director Zeller’s Premarket Tobacco Review Update
- FDA Makes Significant Progress in Science-Based Public Health Application Review, Taking Action on Over 90% of More Than 6.5 Million ‘Deemed’ New Tobacco Products Submitted
August
- FDA Issues Marketing Denials to Over 55,000 Flavored ENDS
- CTPConnect Newsletter: Health Effects of Tobacco Use
- FDA Issues Refuse to File Letter to JD Nova Group LLC
July
- FDA In Brief: FDA Warns Firm With Over 15 Million Products Listed With FDA to Remove Unauthorized E-Cigarette Products from Market
- Spotlight on Science Newsletter
June
- Statement on Withdrawal of the Unified Agenda Entry Pertaining to the Advance Notice of Proposed Rulemaking for Premium Cigars and Related Request for Information
- Event - Deemed Product Review: A Conversation with the Center for Tobacco Products Office of Science
May
- Q&A with CTP's Director of Office of Regulations
- Update on FDA’s Application Review: PMTA List Posted, Progress Metrics Updated
- Spotlight on Science Newsletter
- CTPConnect Newsletter
April
March
February
- CTPConnect Newsletter
- Perspective: FDA’s Progress on Review of Tobacco Product Applications Submitted by the Sept. 9, 2020 Deadline
January
- Spotlight on Science Newsletter
- FDA Marks Historic Public Health Milestone with Finalization of Two Key Rules for Companies Seeking to Market New Tobacco Products
- FDA Warns Firms to Remove Unauthorized E-liquid Products from Market in First Letters Issued to Manufacturers that Did Not Submit Premarket Applications by Deadline
- CBP, FDA Seize Counterfeit, Unauthorized E-Cigarettes
- FDA In Brief: FDA Continues to Collaborate with Scholastic; Launches Student Magazine and Art Contest Encouraging Middle and High School Students Not to Vape
Search for past news and events in the FDA Center for Tobacco Products web archive.
Additional Resources
- About the Center for Tobacco Products
- Leadership
- Commonly Asked Questions: About the Center for Tobacco Products
Paragraph Header
Contact CTP
Food and Drug Administration
Document Control Center
10903 New Hampshire Avenue
Building 71, Room G335
Silver Spring, MD 20993-0002